Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Imported infectious diseases: an update
Simon Tappin - Courtesy Nick Stevens
Simon Tappin

Travel abroad can result in significant risks to animals

In an interesting lecture at BSAVA Congress, Simon Tappin, a European specialist in veterinary medicine, gave a brief update on imported infectious diseases in dogs.

Speaking in the last session of the nursing stream, Simon gave a brief update on some of the diseases starting to be seen in the UK due to increased pet travel and importation of rescued dogs.

Leishmania

Leishmania is one of the most common imported diseases.  It mainly affects dogs and is transmitted by sand flies which can primarily be found in Southern Europe (Spain, Italy, Southern France and Greece).

Classic signs of Leishmania include weight loss, lethargy, anorexia, fever, loss of appetite and exfoliative dermatitis. Diagnosis can be made by identifying the parasite in bone marrow or lymph nodes.  Treatment is a combination of allopurinol with meglumine, antimoniate or miltefosine.

Dirofilaria

Dirofilaria is also commonly found in Southern Europe. The disease is transmitted by mosquitos, with adult worms living in the pulmonary vasculature.

Clinical signs of Dirofilaria include coughing, hypertension and exercise intolerance. Diagnosis is based on demonstrating the presence of microfilariae. Adult worms can either be killed or surgically removed.

Babesia

Babesia is a tick-borne disease which causes anaemia by infecting red blood cells. It is fairly common worldwide and typical signs include weakness, fever and lethargy. Babesia can be treated by injection of imidocarb.

Erlichia

Like Babesia, Erlichia is a tick-born disease but it affects white blood cells instead.  Found primarily in Southern Europe, but present worldwide, the disease leads to signs of fever, enlarged lymph nodes and lethargy.

So what should we tell clients?  

Travel abroad can result in significant risks to individual animals from exposure to these disease, so it is important that clients are aware of them. Simon recommends directing clients to the ESCCAP website  -  a free and independent parasite control resource.

Simon also stressed that it is important to educate clients on how to prevent their pet from contracting these diseases in the first place. "Prevention is better than cure!" he said.  For example, teaching clients about appropriate tick repellents and collars, and explaining the importance of fast and clean tick removal. The quicker the client removes the tick, the less likely their pet will pick up a disease.

Image (C) Nick Stevens

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.